Podcasts about syncthink

They say eyes are windows to the soul; that studying someone's gaze can reveal their innermost emotions. But what can the eyes reveal in a neurological sense, particularly when tracking abnormal eye movement? In this episode of the Global Medical Device Podcast, Jon Speer and Etienne Nichols talk to Scott Anderson, Chief Clinical Officer (CCO) at SyncThink about the groundbreaking work the company is doing in advancing neurological assessments by building and using a proprietary digital health platform based on tracking, capturing, recording, and objectively measuring eye movements.You'll hear how Scott went from his position as Head of Sports Medicine program at Stanford University, where he was part of a multidisciplinary research collaborative studying the natural history of head injuries. Though the technology was initially developed to aid in concussion protocol and the clinical care of athletes with head injuries, the potential of EYE-SYNC technology is now used to diagnose and manage neurodevelopment, neurological function/performance, and neurodegeneration.Some of the highlights of this episode include:SyncThink specializes in neurological assessment by building and using a proprietary digital health platform based on tracking, capturing, recording, and objectively measuring eye movements.Besides concussions, EYE-SYNC technology is used to diagnose and manage neurodevelopment, neurological function/performance, and neurodegeneration.Verbal or motor actions are the result of real-time brain function using the eyes to orient yourself to what's happening and respond in real-time. Neurological deficits in performance occur across one's lifespan due to disease or impairment.SyncThink's EYE-SYNC technology has the potential to proactively prevent health problems in the future. It could facilitate the migration of hospital-based care to consumer-based driven care to preserve brain health. If used as a surveillance or monitoring tool, EYE-SYNC can identify improvement in brain function based on medication deployment. It helps clinicians learn to better titrate medication to specific individuals, such as children with ADHD.Scott admits that he faced logistical challenges and obstacles when doing clinical trials to get the first FDA clearance for following concussion patients. Memorable quotes from Scott Anderson:“There's a whole host of neurological disorders that have a high prevalence of abnormal eye movements associated with it.” “Your eyes actually serve as the window to the brain. It allows you to orient yourself to the things that are happening around you.” “Your brain uses your eyes to select content it wants to interact with.” “Our bread and butter is the software and analytics and the eye tracking measurement, and there's a whole host of these cases for this.” “As technology evolves, too, as well, there will be, I think, several opportunities in order to accelerate the clinical utility of something like eye tracking for a whole host of neurological conditions.” Links:Scott Anderson on LinkedInSyncThinkFDA - Medical Device OverviewFDA - 510(k) ClearancesQ-CollarThe Greenlight Guru True Quality Virtual SummitGreenlight Guru YouTube ChannelMedTech True Quality Stories PodcastGreenlight Guru

In episode forty-two, we speak with Scott Anderson the Chief Clinical Officer at SyncThink about identifying neurological disorders through measuring eye movement, how they use virtual and augmented reality devices to support healthcare professionals, and being a foodie who loves to travel!

Scott Anderson is a recognized concussion expert having spent 4 years at St. Mary's University and 10 years at Stanford as the Director of Athletic Training. He is currently Chief Clinical Officer at SyncThink and is also a Medical Observer for the NFL. In this episode Scott describes what a concussion is, the symptoms, who should diagnose and treat the injury, medical devices used for concussion monitoring, why objective test data is vital, how the SyncThink technology is contributing to concussion management, and the future of eye tracking technology.Links from this episode:Scott Anderson LinkedInSyncThinkMastering Medical Device:WebsitePat Kothe LinkedIn

Scott Anderson was on episode 45 introducing many listeners to SyncThink - where he is the Chief Clinical Officer (CCO) - and describing their EYE-SYNC technology. Per the new release, "the US Food and Drug Administration (FDA) has granted clearance of the EYE-SYNC technology as an Aid to Concussion, or mild Traumatic Brain Injury (mTBI) Diagnosis." Please consider supporting Concussion Talk Podcast on Patreon!

This week's top 5 news from the world of Sports and Technology:

TeachAids is a social venture that grew out of Stanford and Dr. Piya Sorcar's doctoral work. "This effort grew into a collaborative consortium of world-class experts from disciplines including education, medicine, communications, technology, and design thinking. The Institutional Review Board-approved research and methodology has demonstrated statistically significant gains in learning and retention, and provided the highest learning effects and comfort rates of any tested educational approach.1 " Scott Anderson (Episode 45), Chief Clinical Officer (CCO) at SyncThink, former Director of Athletic Training/Sports Medicine at Stanford University and an advisor to TeachAids. Scott was instrumental in the creation of the TeachAids for Concussion product, CrashCourse. He talks about the amazing work that TeachAids is doing, including the incredible FREE CrashCourse products such as the Concussion Story Wall, Concussion Education - including in VR (virtual reality), Brain Fly-Through - including VR!

About Our Guest Laura Yecies is an entrepreneurial leader, strategist, and marketer. She has had a long background in tech including stints on Netscape and Yahoo. She has been consulting with Bone Health Technologies for the last year and was recently named CEO. She was a marketing consultant for Fabric Genomics, helmed SyncThink as CEO, led Catch until they were acquired by Apple, and had tremendous success at SugarSync, a data synchronization company, as their CEO up to their acquisition by J2. Show Notes Laura Yecies covers a number of unique factors that you may be facing in your HealthTech marketing. Targeting your end-user so you can market to your buyer How B2C marketing is influencing B2B marketing How brand plays itself out in the combination of wearable and software tool Why sometimes, the most compelling story to tell is the economic one https://vimeo.com/485297519 Communities, like these Facebook groups, are important to Bone Health Technologies overall marketing efforts Osteopenia and Osteoporosis Support Group Better Bones, Better Body: Osteoporosis & Osteopenia Living with Osteopenia & Osteoporosis Naturally Better Bones Osteoporosis Group Custom photography can showcase how your solution meets a critical need for your buyer. An example from Bone Health’s website. Laura discussed how content has assisted their efforts on the clinical side and the consumer side.

“We are addressing a problem that affects 50 million Americans, half of all women will have a fracture due to low bone density.” -Laura Yecies   Laura Yecies is the CEO of Bone Health Technologies. This company created OsteoBoost, a vibration belt designed to prevent osteoporosis. Laura’s goal is to be involved with innovations to improve health outcomes. She is a serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). She has led multiple successful brands at Check Point, Netscape, and Yahoo.  Laura received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government from Dartmouth. In today’s interview we discuss how OsteoBoost works, who it is intended for, the research, and how it can be part of a comprehensive program for optimal bone health. This is cutting edge information that you don’t want to miss!   Links: OsteoBoost Device Updates List  Bone Health Technologies Find your fracture risk! Get Margie’s posture exercises and stay updated on OsteoBoost and new developments in osteoporosis and more! Timestamps: [02:00] Laura’s introduction: why bones? [05:40] What is OsteoBoost and what does it do? [15:31] How does this tie into the health of not just our bones- but the rest of our body? [17:32] What is Virtuost? What is the future of OsteoBoost? [22:19] More on OsteoBoost: who is suffering from osteopenia? [27:37] Testing for osteoporosis and osteopenia

Welcome to Day 1443 of our Wisdom-Trek, and thank you for joining me.This is Guthrie Chamberlain, Your Guide to WisdomAugmented Reality – Industry Impact – Ask GrampsWisdom - the final frontier to true knowledge. Welcome to Wisdom-Trek! Where our mission is to create a legacy of wisdom, to seek out discernment and insights, to boldly grow where few have chosen to grow before. Hello, my friend, I am Guthrie Chamberlain, your captain on our journey to increase Wisdom and Create a Living Legacy. Thank you for joining us today as we explore wisdom on our 2nd millennium of podcasts. Today is Day 1443 of our Trek, and our focus on Fridays is the future technological and societal advances, so we call it Futuristic Fridays. My personality is one that has always been very future-oriented. Since my childhood, I have yearned for the exploration and discovery of new technologies and advancements for the future. I grew up with the original Star Trek series, and even today, while I am on my 64th revolution around the sun, I still dream of traveling in space. Each week we will explore rapidly converging technologies and advancements, which will radically change our lives. At times, the topics may sound like something out of a science fiction novel, but each area that we explore is already well on its way of becoming a reality over the next couple of decades. To keep with our theme of “Ask Gramps,” I will put our weekly topics in the form of a question to get us on track. So this week's question is: Hey Gramps, I understand that Augmented Reality will have a significant impact on our lives, but can you share how it may impact specific industries?  Augmented Reality – Industry ImpactLast week on Futuristic Friday, we explored hardware and apps that are used as instruments for Augmented Reality (AR). Today, we will focus on a few specific industries which will be most impacted with AR. Our world is in a disruptive mode, which will speed up the exponential technology that is changing our world today. I am using some of the information mentioned in Peter Diamandis's blogs and book “The Future is Faster Than You Think.” Augmented Reality (AR) has already exceeded over 2,000 AR apps on over 1.4 billion active iOS devices. Even if on a rudimentary level, the technology is now permeating the consumer products space. And in just the next four years, the International Data Corporation (IDC) forecasts AR headset production will surge 141 percent each year, reaching a whopping 32 million units by 2023. AR will soon serve as a surgeon's assistant, a sales agent, and an educator, personalized to your kids' learning patterns and interests. I'm doing a deep dive into AR's most exciting industry applications, poised to hit the market in the next 5-10 years. Let's dive in. Healthcare(1) Surgeons and physicians:  Whether through detailed and dynamic anatomical annotations or visualized patient-specific guidance, AR will soon augment every human medical practitioner. To start, AR is already being used as a diagnosis tool. SyncThink, recently hired by Magic Leap, has developed eye-tracking technology to diagnose concussions and balance disorders. Yet another startup, XRHealth, launched its ARHealth platform on Magic Leap to aid in rehabilitation, pain distraction, and psychological assessment. Moreover, surgeons at the Imperial College London have used Microsoft's HoloLens 1 in pre-operative reconstructive and plastic surgery procedures, which typically involves using CT scans to map blood vessels that supply vital nutrients during surgery. As explained by the project's senior researcher, Dr. Philip Pratt, “With the HoloLens, we're now doing the same kind of [scan] and then processing the data captured to make it suitable to look at. That means we end up with a silhouette of a limb, the location of the injury, and the course of the vessels through the area, as opposed to...

Chief Clinical Officer of SyncThink, Scott Anderson, discusses a novel technology capable of identifying eye movements that indicate the presence of certain neurological conditions. In this episode, you'll discover: How common neurological conditions are diagnosed (it might not be how you think) What types of eye movements are associated with neurological impairments What the future of eye tracking looks like Most neurological conditions lack objective diagnostic tools, which means diagnoses are made only by the exclusion of others, and heavily reliant upon the patient's reported experiences or answers on standardized questionnaires. This includes developmental conditions often labeled as learning disabilities in children, and degenerative conditions in late life, such as dementia. Until now, there has been no method for functionally measuring the brain to determine what is actually going on with patients who present with certain signs or symptoms. For the past 15 years, Stanford neurosurgeon Dr. Ghajar has been capturing, studying, identifying, and classifying eye movements and correlating them with various neurological conditions in partnership with the US Department of Defense.  With the help of today's guest, Scott Anderson, the data gathered from this extensive research has been commercialized, and is now available as an unprecedented tool for objectively measuring evidence of neurological impairments and conditions.    The technology utilizes FDA-approved, high-fidelity, research-grade eye tracking infrared cameras and emitters built into virtual reality goggles, and conducts a series of 60-second assessments to capture eye movements. Anderson explains the specifics of the treatments and exercises used in this field, how to improve the standard and quality care for concussions, the future of eye tracking, and more. Tune in and visit https://syncthink.com/.

How can we improve eye tracking for a more accurate assessment of someone's neurocognitive function? What is someone's likelihood of developing dementia? What's the best treatment for patients with substance abuse disorder or depression that effectively engages them in treating their conditions? The relatively new field of digital treatments and diagnostics offers valuable answers to critical medical questions such as these. It's a space where the healthcare industry is currently on the leading edge of change, moving from what was once mere theory and conjecture to rapid change and adoption as these types of technologies become more readily available. In this episode, three healthcare leaders — David Benshoof Klein, Executive Chairman, President, and Chief Executive Officer at Click Therapeutics, Laura Yecies, former Chief Executive Officer at SyncThink, and Trip Hofer, Chief Executive Officer at AbleTo — explore with host Fritz Heese, a Health & Life Sciences Partner at Oliver Wyman, at the 2019 Oliver Wyman Health Innovation Summit in Chicago why digital therapeutics are on the cusp of becoming mainstream and what specific problems digital treatments may solve within the next five years. For more information, follow us on Twitter @OWHealthEditor, read our online healthcare publication at health.oliverwyman.com, and see our guest roster: oliverwyman.com/oliverwymanhealthpodcast. Questions or comments? Email Oliver Wyman Health's Editor, jacqueline.dichiara@oliverwyman.com.

Did you know that 50% of concussions go unreported or undetected.  If you or a loved one had a concussion, what signs would you look for?  What should you do if you think you or your child has had a concussion?  How can clinicians collect objective data to make better-informed decisions about the nature of impairment, and the corresponding treatment needed to optimize recovery?  In this episode of DeviceAlliance’s Medtech Radio, we speak with Chief Clinical Officer of SyncThink, Inc. and Medical Observer for the NFL, Scott Anderson.  Join us as he shares his clinical expertise on what exactly a concussion is, signs of recognizing a concussion in yourself and others, and how SyncThink is assisting medical professionals in assessing brain health, monitoring health, and optimizing performance.  Scott also shares his experience with working at NFL games for the past seven years, and how the culture of concussion diagnosis and care has changed.

stdout.fm 50번째 로그에서는 The Cloud 100, 기기 간 동기화 앱 Syncthink, Notion 학생 무료 플랜 공개 등에 대해서 이야기를 나눴습니다. The Cloud 100 The Cloud 100 2019 HashiCorp…

stdout.fm 50번째 로그에서는 The Cloud 100, 기기 간 동기화 앱 Syncthink, Notion 학생 무료 플랜 공개 등에 대해서 이야기를 나눴습니다. 참가자: @seapy, @nacyo_t, @raccoonyy The Cloud 100 The Cloud 100 2019 HashiCorp: Infrastructure enables innovation Zapier | The easiest way to automate your work 2017 GDP comparison by country or US state - Economy of California - Wikipedia 블랙넛 모욕죄 처벌, 예술작품에 대한 국가권력 개입을 우려한다 | Open Net if (kakao) dev 2019 영상 공개 if (kakao) dev 2019 프로그램 AWS Summit Seoul 당근마켓 팀블로그 – Medium kthcorp H3 컨퍼런스 재생목록 - YouTube 카카오톡 적용 사례를 통해 살펴보는 카카오 클라우드의 Kubernetes as a Service 자동화된 클라우드를 위하여 - if (kakao) dev 2019 기기간 동기화 앱 Syncthing 싱크띵(Syncthing), 여러 기기간 파일 동기화 애플리케이션: 드롭박스 대신 무료로 가능한 오픈소스 프로젝트 | 44bits.io Syncthing Subscribe to Bear Pro - Bear - Faq and support DEVONtechnologies | DEVONthink 3.0 is Officially Here Bear 1.7 is here with note Encryption, Bear Lock, Live Note Links, and more! Notion 학생 무료 플랜 제공 Notion – Free for students Notion – Free for educators 구글 코드리뷰 가이드 라인 Code Review Developer Guide | eng-practices Review · Soojin Ro Introduce for code review guide | Lucas’s wiki FECONF 2019 JSConf Korea 2019 | JSConf Korea FEConf 2019 네이버 예약 - FECONF FEConf 2018 | Festa! FEconf 2019 Promotional Video - YouTube FEConf 2018 Korea - YouTube 44bits - YouTube

Scott Anderson is the CCO (Chief Clinical Officer) of SyncThink, a company founded by neurosurgeon Dr. Jamshid Ghajar, that produces the EYE-SYNC device - a technology that uses eye-tracking and virtual reality to diagnose fatigue and brain impairments. It’s currently in use by 3 NBA Teams, the Pac-12 Athletic Conference of the NCAA, and 2 Children’s hospitals. Scott was on Stanford University’s Sports Medicine Program for 10 years, worked with Dr. Jamshid Ghajar on a collaborative study on head injuries, and is also an internationally recognized speaker on head injury management. As well as CCO of SyncThink, he currently serves as a consultant to the NFL and was previously the Chair of the Pac-12 Sports Medicine Committee. Athlete advisors to SyncThink include: Taylor Twellman (former US national soccer team and current ESPN analyst), Coby Fleener (NFL tight end), and Steve Young (NFL Hall of Fame quarterback).

Laura Yecies has an incredible list of Silicon Valley companies on her resume, including Yahoo!, Catch.com, SugarSync, and Netscape following the AOL acquisition. She has been the CEO of two venture-backed startups, including her current role as CEO of SyncThink, an eye-tracking technology with profound implications for neurological health.  In this episode, Laura and Melinda discuss balancing a family and a tech career (and how we need to start asking this question of men as well as women), and what it was like to walk into a room of 50 CEOs and realize she’s the only female. Laura offers recommendations for books, advice for managers, supportive words for females in tech, and nuggets of wisdom for married couples trying to nurture two careers at once.  LINKS MENTIONED IN THIS EPISODE: Lean In: Women, Work, and the Will to Lead, by Sheryl Sandberg Brogrammer culture article from Inc.: New Report: Sexism in Silicon Valley Is Really Pretty Awful Moneyball: The Art of Winning an Unfair Game, by Michael Lewis State Department of Justice lawsuit against Microsoft Wikipedia article Laura’s recommendations for Behavioral Economics books:  Misbehaving by Richard Thaler  Thinking Fast and Slow by Daniel Kahneman  Predictably Irrational by Dan Ariely MUSICAL INSPIRATION FOR THIS EPISODE ON SPOTIFY: "Good Life" by OneRepublic ABOUT THIS PODCAST  Stayin' Alive in Tech is an oral history of Silicon Valley and technology. Melinda Byerley, the host, is a 20-year veteran of Silicon Valley and the founder of Timeshare CMO, a digital marketing intelligence firm, based in San Francisco. We really appreciate your reviews, shares on social media, and your recommendations for future guests. And check out our Spotify playlist for all the songs we refer to on our show. 

On today’s show, the guys welcome Scott Anderson, Chief Clinical Officer at SyncThink and advisor for CrashCourse by TeachAids (teachaids.org), talking about their newest health initiative. There’s an EAST Initiative update, some banter between the guys and more. Up next on the EduTechGuys. Music: https://www.purple-planet.com http://CU-Portland.edu/letsconquer

The conversation started as an introduction to the Syncthink technology that helps treat head injury but morphed into the other potential uses including working with kids to help curb learning disabilities and ADD..  Plus, Kevin Kleps discusses the Indians use of Clear security methods to help fans get into Indians games quicker and Matt Foley from Ozy discusses how teams are tracking their fans interests. 

SyncThink develops revolutionary eye-tracking technology analytics, now in VR headsets, that give medical professionals objective metrics for visual attention and dynamic orientation. Based on 15 years of research and 12 granted patents, SyncThink’s first product, EYE-SYNC, is a 60-second, objective sideline assessment that uses eye tracking to evaluate for ocular motor impairments and vestibular balance dysfunction – the two most common and serious components of concussion. FDA-cleared for detecting eye-tracking impairment, EYE-SYNC is used by leading university athletic departments and medical clinics, from Stanford University to Massachusetts General Hospital, EYE-SYNC is transforming brain health assessment, recovery, and monitoring. Guest Info Laura Yecies is the CEO of SyncThink, as a Silicon Valley veteran, she has successfully led multiple startups and top brands. As CEO of SugarSync, she led the company for four years through an aggressive business and product growth phase growing from zero to $25M in revenue and signed several strategic partnerships leading to significant valuation increases. SugarSync was later acquired by J2Global. She joined the Catch.com team as acting CEO to help develop the company’s business model, where they expanded the product footprint and built strategic alliances, before successfully selling the company to Apple in 2013.   For the six years after leaving Informix, she was the Vice President of the Netscape browser division at AOL where she was responsible for the development of Netscape 7.0 and the launch of the Netscape browser in 23 languages. After leaving NetScape, she joined Yahoo where she served as the Global General Manager for the Yahoo Mail division. Following her time at Yahoo, Yecies was the VP of Marketing at Check Point Software where she served for three years.  Prior to the aforementioned, Yecies led marketing programs and Latin American sales at Informix Software Corp for six years. She’s been the recipient of many awards such as the 2011 Gold Medal and 2012 Silver Medal for Female Executive of the Year for the Stevie Award for Women in Business, the Inc. 500 — Top Female CEO of 2012, and was a previous U.S. Department of State TechWoman Mentor.          

Is it possible that too much has been made of CTE in NFL Players? Scott Anderson, Chief Customer Officer at SyncThink sits with Bram to discuss that and much more related to the science behind the study of head trauma.